{"id":62398,"date":"2025-12-23T04:05:51","date_gmt":"2025-12-23T03:05:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/"},"modified":"2025-12-23T04:05:51","modified_gmt":"2025-12-23T03:05:51","slug":"kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/","title":{"rendered":"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<i>The INR 648 crore facility will drive investment in state-of-the-art biologics manufacturing facility in Pipan, Gujarat<\/i><\/li>\n<li>\n<i>The facility will enhance technical capabilities, improve global competitiveness, and create long-term, high-value employment across scientific, technical, and operational disciplines<\/i><\/li>\n<\/ul>\n<p>AHMEDABAD, India&#8211;(BUSINESS WIRE)&#8211;Kashiv BioSciences Private Limited (\u201cKashiv\u201d), a biopharmaceutical company, today announced that it has secured financing of INR 648 crore from the Union Bank of India. The proceeds will be used to expand its state-of-the-art manufacturing facility in Pipan, near Ahmedabad, Gujarat.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/5\/Kashiv_BioSciences_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/22\/Kashiv_BioSciences_Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/5\/Kashiv_BioSciences_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/21\/Kashiv_BioSciences_Logo.jpg\"><\/a><\/p>\n<p>\nThe new single-use commercial manufacturing facility will be one of India\u2019s largest, equipped with cutting-edge technologies to support the production of high-quality biologics and specialty pharmaceuticals. At full capacity, Kashiv expects the facility to manufacture up to 50,000L. This milestone represents a major step forward in Kashiv\u2019s mission to expand its global footprint and strengthen its position in India as a leading center for advanced biopharmaceutical manufacturing.<\/p>\n<p>\nServing customers across the U.S., Canada, Europe, and other international markets, the facility will further reinforce India\u2019s role as the \u201cpharmacy of the world\u201d by enhancing technical capabilities, improving global competitiveness, and creating long-term, high-value employment across scientific, technical, and operational disciplines.<\/p>\n<p>\n\u201cThis funding marks a pivotal milestone in Kashiv\u2019s journey to expand biomanufacturing capacity in India,\u201d <b>said Dr. Sandeep Athalye, Global CEO of Kashiv BioSciences<\/b>. \u201cThe new facility in Pipan will not only accelerate innovation and access to high-quality biologics but also reinforce our commitment to building world-class infrastructure that supports global healthcare needs. This infrastructure is being financed with the support of the Union Bank of India and is in alignment with the Biotechnology Policy and schemes implemented by GSBTM (Gujarat State Biotechnology Mission), a body of the state government, which continues to catalyze investment in advanced biopharmaceutical manufacturing.\u201d<\/p>\n<p>\n<b>Shri Digvijaysinh D. Jadeja, IAS, Mission Director (MD) of the GSBTM said,<\/b> \u201cKashiv\u2019s expansion in Pipan exemplifies Gujarat\u2019s commitment to fostering innovation-led growth in biotechnology. Through the Biotechnology Policy, we continue to support high-impact investments that elevate India\u2019s scientific capabilities and create meaningful employment across the value chain.\u201d<\/p>\n<p>\n\u201cUnion Bank is proud to have partnered with Kashiv as the lender on this initiative. This will advance India\u2019s manufacturing capabilities and create sustainable economic value for the region, supporting the nation in achieving its goal of \u2018Viksit and Atmanirbhar Bharat\u2019. We wish the Company great success in this endeavor,\u201d <b>said a senior representative from the Union Bank of India.<\/b><\/p>\n<p>\n<b>About Kashiv BioSciences:<\/b><\/p>\n<p>\nKashiv BioSciences Private Limited, a fully owned subsidiary of Kashiv BioSciences, LLC is a biopharmaceutical company with numerous commercial and advanced clinical-stage assets and is among the few companies to both manufacture and receive marketing authorization for multiple biosimilars. Kashiv BioSciences, LLC in the USA, and its subsidiaries in India (together \u201cKashiv BioSciences\u201d) operate together with robust infrastructure and highly skilled teams that provide global R&amp;D, clinical, manufacturing, regulatory, and IP capabilities. We believe our people, partners, and shared purpose fuel our work to advance patient care and access to important medicines.<\/p>\n<p>\nFor more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.kashivbiosciences.com&amp;esheet=54382559&amp;newsitemid=20251222934735&amp;lan=en-US&amp;anchor=www.kashivbiosciences.com&amp;index=1&amp;md5=c9026d8778aa66ce79f66aeb5bb5006a\" rel=\"nofollow\" shape=\"rect\">www.kashivbiosciences.com<\/a> and follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fkashivbiosciences&amp;esheet=54382559&amp;newsitemid=20251222934735&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=acb05d37f1b05557ca7b92886813e761\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Kashiv Biosciences Contacts:<\/b><br \/><b>Dr. Paras Vasanani<\/b><br \/>Head \u2013 Business Development<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;p&#97;&#x72;a&#x73;&#x2e;&#118;&#x61;s&#97;&#x6e;a&#x6e;&#x69;&#64;&#x6b;a&#115;&#x68;&#105;&#x76;b&#105;&#x6f;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow\" shape=\"rect\">&#x70;&#x61;&#114;a&#x73;&#x2e;&#x76;&#97;s&#x61;&#x6e;&#x61;&#110;i&#x40;&#x6b;&#x61;&#115;h&#x69;&#x76;&#x62;&#105;o&#x2e;&#x63;&#x6f;&#109;<\/a><\/p>\n<p>\n<b>Heena Dhedhi<\/b><br \/>Head \u2013 Corporate Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x68;&#x65;&#x65;&#x6e;&#x61;&#x2e;&#x64;&#x68;&#x65;&#x64;&#x68;&#x69;&#x40;&#x6b;&#x61;&#115;&#104;&#105;&#118;&#98;&#105;&#111;&#46;&#99;&#111;&#109;\" rel=\"nofollow\" shape=\"rect\">&#104;&#x65;&#x65;n&#97;&#x2e;d&#104;&#x65;&#x64;&#104;&#x69;&#x40;k&#97;&#x73;h&#105;&#x76;&#x62;&#105;&#x6f;&#x2e;c&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The INR 648 crore facility will drive investment in state-of-the-art biologics manufacturing facility in Pipan, Gujarat The facility will enhance technical capabilities, improve global competitiveness, and create long-term, high-value employment across scientific, technical, and operational disciplines AHMEDABAD, India&#8211;(BUSINESS WIRE)&#8211;Kashiv BioSciences Private Limited (\u201cKashiv\u201d), a biopharmaceutical company, today announced that it has secured financing of INR &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62398","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The INR 648 crore facility will drive investment in state-of-the-art biologics manufacturing facility in Pipan, Gujarat The facility will enhance technical capabilities, improve global competitiveness, and create long-term, high-value employment across scientific, technical, and operational disciplines AHMEDABAD, India&#8211;(BUSINESS WIRE)&#8211;Kashiv BioSciences Private Limited (\u201cKashiv\u201d), a biopharmaceutical company, today announced that it has secured financing of INR ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-23T03:05:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/22\/Kashiv_BioSciences_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India\",\"datePublished\":\"2025-12-23T03:05:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/\"},\"wordCount\":555,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251222934735\\\/en\\\/2676736\\\/22\\\/Kashiv_BioSciences_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/\",\"name\":\"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251222934735\\\/en\\\/2676736\\\/22\\\/Kashiv_BioSciences_Logo.jpg\",\"datePublished\":\"2025-12-23T03:05:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251222934735\\\/en\\\/2676736\\\/22\\\/Kashiv_BioSciences_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251222934735\\\/en\\\/2676736\\\/22\\\/Kashiv_BioSciences_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/","og_locale":"en_US","og_type":"article","og_title":"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India - Pharma Trend","og_description":"The INR 648 crore facility will drive investment in state-of-the-art biologics manufacturing facility in Pipan, Gujarat The facility will enhance technical capabilities, improve global competitiveness, and create long-term, high-value employment across scientific, technical, and operational disciplines AHMEDABAD, India&#8211;(BUSINESS WIRE)&#8211;Kashiv BioSciences Private Limited (\u201cKashiv\u201d), a biopharmaceutical company, today announced that it has secured financing of INR ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-23T03:05:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/22\/Kashiv_BioSciences_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India","datePublished":"2025-12-23T03:05:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/"},"wordCount":555,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/22\/Kashiv_BioSciences_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/","url":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/","name":"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/22\/Kashiv_BioSciences_Logo.jpg","datePublished":"2025-12-23T03:05:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/22\/Kashiv_BioSciences_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251222934735\/en\/2676736\/22\/Kashiv_BioSciences_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/kashiv-biosciences-secures-inr-648-crore-financing-from-union-bank-of-india-to-expand-manufacturing-facilities-in-gujarat-india\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62398"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62398\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}